Quantitative motor readouts as provided by QuantiMedis have been used in the following clinical trials / studies:

• CAFQ056A2207 in Huntington's disease Sponsor: Novartis Pharma, Basel, Switzerland (EUDRACT2009-011743-39/NCT01019473)
• CAQW051A2209 in Parkinson's disease Sponsor: Novartis Pharma, Basel, witzerland (EUDRACT2011-001092-39/NCT01474421)
• ACTION-HD in Huntington's disease Sponsor: Charité Berlin, Germany (EUDRACT2009-013698-16)
• ETON in Huntington's disease Sponsor: Charité Berlin, Germany (EUDRCCT2010-023941-31/NCT01357681)
• TRACK-HD in Huntington's disease Sponsor: CHDI Foundation, New York, USA
• TRACK-ON-HD in Huntington's disease Sponsor: CHDI Foundation, New York, USA
• PREDICT-HD in Huntington's disease Sponsor: NIH, Bethesda B. CHDI Foundation, New York, USA